|Day Low/High||2,550.00 / 2,600.00|
|52 Wk Low/High||2,020.00 / 2,614.00|
Monsanto (MON) stock is down on Wednesday morning as the company posted weak earnings results and said it no longer sees ‘large-scale’ mergers and acquisition as a strategy.
Stocks fluctuate on Wednesday as a rally in crude oil fails to ignite big gains on Wall Street.
It is the third time in five quarters that it misses earnings expectations.
Monsanto (MON) stock is lower on Wednesday morning after the company posted lower-than-expected results for the 2016 fiscal second quarter before today’s market open.
Monsanto reported a 13% decline in quarterly revenue.
Stock futures edge higher on Wednesday, recovering from a selloff a day earlier, as crude oil spikes on hopes of a production freeze among major oil-producing countries.
Monsanto Company (NYSE: MON): FY16 as-reported EPS guidance improves to $3.
U.S. stock futures are signaling a rebound for Wall Street on Wednesday. Pfizer confirms it terminated its $160 billion merger deal with Allergan.
In addition to Monsanto, Constellation Brands and Bed Bath & Beyond are also expected to release quarterly results.
In 'What to Watch on Wall Street' for Wednesday April 6, we've got three big companies reporting quarterly numbers.
Monsanto (MON) shares are lower on expectations that the company will report a year-over-year decline in Q2 profit and revenue.
Signs of 'just right' economic growth are contrasting with falling earnings and rising energy debt. Can the market rally stay on track, or does it have a rendezvous with recession?
A number of companies will be reporting earnings this week, and there will be fresh economic data to study.
In 'What's Ahead on Wall Street' for the week of April 4, we've got several key companies we're watching on the earnings front.
Monsanto Company (NYSE: MON) announced it will issue the company's financial results for its fiscal 2016 second quarter on Wednesday, April 6, 2016, prior to market open.
Monsanto Company (NYSE: MON) announced today the appointment of Mitch Barns to the company's board of directors.
TheStreet highlights 3 stocks pushing the basic materials sector lower today.
Monsanto has become a major force in biotechnology, by using it to develop new kinds of seeds and agricultural systems.
Monsanto (MON) is reportedly considering crop deals with BASF and Bayer.
U.S. stock futures point to slight gains for Wall Street on Monday.
European stocks rise Monday while Asian shares move higher.
TheStreet highlights 3 stocks pushing the chemicals industry lower today.
Here are Monday's top research calls, including upgrades for Big Lots, Johnson & Johnson and Tesla, and new coverage for Macy's.
It's time to unload these toxic stocks from your portfolio.
The Climate Corporation, a division of Monsanto Company (NYSE: MON), announced data connectivity agreements with several agronomic and retailer software systems as well as the John Deere Operations Center, enabling farmers...
Monsanto (MON) shares are under pressure Friday morning after Goldman Sachs downgraded the company and reduced its price target.
A cut to profit forecasts and a bleak performance by the market for agricultural staples helps pull the biotech giant to the bottom of the index.
There were a lot of bumps during Wednesday's trading, but stocks essentially went nowhere: blame uncertainty over oil and the Federal Reserve.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.